Results 291 to 300 of about 30,434 (317)
Some of the next articles are maybe not open access.
Gastroenterology Clinics of North America, 2015
Prokinetic agents are medications that enhance coordinated gastrointestinal motility and transit of content in the gastrointestinal tract, mainly by amplifying and coordinating the gastrointestinal muscular contractions. In addition to dietary therapy, prokinetic therapy should be considered as a means to improve gastric emptying and symptoms of ...
Andres Acosta, Michael Camilleri
openaire +3 more sources
Prokinetic agents are medications that enhance coordinated gastrointestinal motility and transit of content in the gastrointestinal tract, mainly by amplifying and coordinating the gastrointestinal muscular contractions. In addition to dietary therapy, prokinetic therapy should be considered as a means to improve gastric emptying and symptoms of ...
Andres Acosta, Michael Camilleri
openaire +3 more sources
Current Opinion in Gastroenterology, 2012
Gastroparesis is a common disorder that produces symptoms of gastric retention in the absence of physical obstruction. Extensive research into the clinical features, pathophysiology, diagnostic evaluation, and therapy of gastroparesis in the past several years has offered insight into the condition.
openaire +2 more sources
Gastroparesis is a common disorder that produces symptoms of gastric retention in the absence of physical obstruction. Extensive research into the clinical features, pathophysiology, diagnostic evaluation, and therapy of gastroparesis in the past several years has offered insight into the condition.
openaire +2 more sources
Alimentary Pharmacology and Therapeutics, 2021
Gastroparesis is a serious gastrointestinal (GI) condition characterised by delayed gastric emptying (GE). Velusetrag—a potent, selective, pan‐gastrointestinal 5‐hydroxytryptamine type 4 receptor agonist—is under investigation for treatment of GI ...
B. Kuo +7 more
semanticscholar +1 more source
Gastroparesis is a serious gastrointestinal (GI) condition characterised by delayed gastric emptying (GE). Velusetrag—a potent, selective, pan‐gastrointestinal 5‐hydroxytryptamine type 4 receptor agonist—is under investigation for treatment of GI ...
B. Kuo +7 more
semanticscholar +1 more source
Pharmacotherapy of gastroparesis
Expert Opinion on Pharmacotherapy, 2009Gastroparesis is a relatively common and often disabling condition that is characterized by a broad range of clinical presentation ranging from dyspeptic symptoms to nausea, vomiting, abdominal pain, malnutrition, frequent hospitalizations and incapacitation.
Richard W. McCallum, Savio C. Reddymasu
openaire +2 more sources
Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study.
American Journal of Gastroenterology, 2019OBJECTIVES Prokinetics are considered the preferred treatment option for gastroparesis, but evidence of their efficacy is scarce. Prucalopride, a selective 5-hydroxytryptamine 4 receptor agonist used in the treatment of constipation, is able to enhance ...
F. Carbone +10 more
semanticscholar +1 more source
Gastroenterology Clinics of North America, 2015
Gastroparesis is a complication of long-standing type 1 and type 2 diabetes mellitus. Symptoms associated with gastroparesis include early satiety, prolonged postprandial fullness, bloating, nausea and vomiting, and abdominal pain. Mortality is increased in patients with diabetic gastroparesis.
Kenneth L, Koch, Jorge, Calles-Escandón
openaire +2 more sources
Gastroparesis is a complication of long-standing type 1 and type 2 diabetes mellitus. Symptoms associated with gastroparesis include early satiety, prolonged postprandial fullness, bloating, nausea and vomiting, and abdominal pain. Mortality is increased in patients with diabetic gastroparesis.
Kenneth L, Koch, Jorge, Calles-Escandón
openaire +2 more sources
Expert Review of Gastroenterology & Hepatology, 2008
Gastroparesis presents with nausea, vomiting, early satiety and abdominal discomfort, as well as a range of nongastrointestinal manifestations in association with delays in gastric emptying. The disorder may be a consequence of systemic illnesses, such as diabetes mellitus, occur as a complication of gastroesophageal surgery or develop in an idiopathic
openaire +3 more sources
Gastroparesis presents with nausea, vomiting, early satiety and abdominal discomfort, as well as a range of nongastrointestinal manifestations in association with delays in gastric emptying. The disorder may be a consequence of systemic illnesses, such as diabetes mellitus, occur as a complication of gastroesophageal surgery or develop in an idiopathic
openaire +3 more sources
Diabetic Medicine, 2005
The definitive version is available at onlinelibrary.wiley.com Article first published online: 15 AUG 2005 ; M.-F.
Kong, M., Horowitz, M.
openaire +3 more sources
The definitive version is available at onlinelibrary.wiley.com Article first published online: 15 AUG 2005 ; M.-F.
Kong, M., Horowitz, M.
openaire +3 more sources
Gastroenterology Nursing, 2006
Gastroparesis is a manifestation of diabetic autonomic neuropathy. Gastrointestinal autonomic neuropathy contributes to morbidity, mortality, reduced quality of life, and increased healthcare costs of a patient with diabetes mellitus. Complications from gastroparesis include ketoacidosis, infection, and bezoar formation.
openaire +2 more sources
Gastroparesis is a manifestation of diabetic autonomic neuropathy. Gastrointestinal autonomic neuropathy contributes to morbidity, mortality, reduced quality of life, and increased healthcare costs of a patient with diabetes mellitus. Complications from gastroparesis include ketoacidosis, infection, and bezoar formation.
openaire +2 more sources